Cytokinetics, Inc. (CYTK)
61.70
+0.98
(+1.61%)
USD |
NASDAQ |
Mar 04, 13:25
Cytokinetics Research and Development Expense (Annual) : 405.90M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Bristol Myers Squibb Co. | 9.492B |
| Molina Healthcare, Inc. | -- |
| Lifecore Biomedical, Inc. | 8.258M |
| Corcept Therapeutics, Inc. | 254.91M |
| Ionis Pharmaceuticals, Inc. | 913.18M |